13F-HR filed by Foresite Capital Management V, LLC
Foresite Capital Management V, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 6 holding rows worth $120,193,232.
- Accession
- 0001104659-25-013930
- Filer
- CIK 1792206
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 6 entries on the cover page, a total value of $120,193,232 stated on the cover page (in dollars after the unit check, H1), rows summing to $120,193,232 with VALUE read as dollars as filed, 13F file number 028-20850. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALUMIS INC | 022307102 | COM | 5,779,348 | $45,425,675 | dollars as filed | |
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 939,860 | $22,725,815 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 692,550 | $19,862,334 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 299,069 | $18,960,975 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 657,905 | $8,013,283 | dollars as filed | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 8,133,047 | $5,205,150 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-25-013930 | this filing | 2025-02-14 | acceptance time not in the bulk data set |